Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector?

Valued at $17 billion by market cap, Quest Diagnostics Incorporated (DGX) is a prominent provider of diagnostic testing services. The Secaucus, New Jersey-based company specializes in providing a broad range of diagnostic information services, including clinical testing and risk assessment solutions, both in the U.S. and internationally.

Companies worth $10 billion or more are generally described as “large-cap stocks,” and DGX effortlessly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the diagnostics and research industry.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.